Generally, it is believed that abnormal activation of microglia and astrocytes is a deleterious event during AD onset, and inhibition of malignant glial response to pathological Aβ and tau, as well as blockade of pro-inflammatory cytokine release may impede AD pathogenesis. This evidence concerns the gene MAPT and Alzheimer disease.